Effects of a long-acting somatostatin analogue, lanreotide, on bile duct ligation-induced liver fibrosis in rats

Sadeleştirilmiş öğe sayfası
dc.contributor.authorTahan, Gulgun
dc.contributor.authorEren, Fatih
dc.contributor.authorTarcin, Orhan
dc.contributor.authorAkin, Hakan
dc.contributor.authorTahan, Veysel
dc.contributor.authorSahin, Hulya
dc.contributor.authorOzdogan, Osman
dc.contributor.authorImeryuz, Nese
dc.contributor.authorCelikel, Cigdem
dc.contributor.authorAvsar, Erol
dc.contributor.authorTozun, Nurdan
dc.date.accessioned2025-10-16T15:38:48Z
dc.date.issued2010
dc.identifier.doi10.4318/tjg.2010.0102
dc.identifier.otherWOS:000283606300015
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/9823
dc.publisherAVES
dc.sourceTURKISH JOURNAL OF GASTROENTEROLOGY
dc.subjectAnti\\-fibrotic
dc.subjectsomatostatin analogue
dc.subjectlanreotide
dc.subjectbile duct ligation
dc.subjecthepatic fibrosis
dc.subjectliver
dc.titleEffects of a long-acting somatostatin analogue, lanreotide, on bile duct ligation-induced liver fibrosis in rats
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS